Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257997 · ClinicalTrials.gov registry record
Quantification of Human Adipogenesis
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 20
- Enrollment target
NCT01257997: Completed study, sponsored by Brigham and Women's Hospital.
NCT01257997 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01257997 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This pilot study is using a novel technology to measure the rate of turnover of new fat cells. Analysis of volunteer samples is ongoing, however the study is currently not enrolling new volunteers.
Interventions
- BIOLOGICAL 15N-Thymidine, 2H-Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2017-01 |
What the finished NCT01257997 record still lists
NCT01257997 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 15N-Thymidine, 2H-Water is the first listed.
NCT01257997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01257997 about?
NCT01257997 is a clinical study titled "Quantification of Human Adipogenesis". This pilot study is using a novel technology to measure the rate of turnover of new fat cells. Analysis of volunteer samples is ongoing, however the study is currently not enrolling new volunteers.
What is the current status of trial NCT01257997?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01257997?
The interventions under investigation include: 15N-Thymidine, 2H-Water (BIOLOGICAL).
Who is sponsoring clinical trial NCT01257997?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia